Christina Östberg Lloyd

Christina Östberg Lloyd has a diverse and extensive work experience in the healthcare industry. Christina is currently working as the Senior Vice President of Reproductive Medicine and Maternal Health at Ferring Pharmaceuticals, where they oversee the company's portfolio in this therapy area. Prior to that, they served as the CEO of Pharmiva AB, focusing on medical and medtech innovation in Women's Health. Christina has also held leadership positions at Forsknings & Innovationsrådet Skåne, Novo Nordisk Scandinavia AB, Swelife, Ferring Pharmaceuticals, and Lunds Universitets sjukhus. Christina'sexpertise lies in various areas such as clinical medical regulatory, gynecology, obstetrics, and reproductive medicine.

Christina Östberg Lloyd completed their Medical Doctor degree specializing in Medicine Spec.Gynaecology and Obstetrics from Lund University between 1983 and 1988. Christina later pursued further education in Medical Business Strategy at SIMI Scandinavian International Management Institute Copenhagen in 2006. In 2014, they obtained a degree from Executive Foundation Lund (EFL). In 2019, Christina attended IMD for Leadership and Business Strategy as a Management member at Novo Nordisk.